As angiotensin II levels are elevated in CKD, this data suggests a potential mechanism by which megalin expression and function are inhibited in kidney diseases, potentially leading to detrimental effects on vitamin D metabolism [115]. The gene discussed is LRP2; the disease is chronic kidney disease.